Affordable Access

Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs.

Authors
  • 1
Type
Published Article
Journal
Journal of Clinical Epidemiology
0895-4356
Publisher
Elsevier
Publication Date
Volume
58
Issue
1
Pages
92–97
Identifiers
PMID: 15649676
Source
Medline

Abstract

Evidence that higher doses of short-acting inhaled beta(2)-agonists are associated with higher mortality from COPD was consistently supplied by three observational approaches.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F